Shelton Capital Management Exact Sciences Corp Transaction History

Shelton Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$77.66 - $99.74 $424,567 - $545,278	-5,467 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$90.37 - $122.49 $494,052 - $669,652	5,467 New	5,467 $494,000
Q2 2018 Aug 10, 2018	SELL	$37.84 - $69.96 $332,992 - $615,648	-8,800 Closed	0 $0
Q3 2017 Nov 28, 2017	BUY	$37.05 - $47.12 $326,040 - $414,656	8,800 New	8,800 $415,000
Q3 2017 Nov 14, 2017	SELL	$37.05 - $47.12 $326,040 - $414,656	-8,800 Closed	0 $0
Q1 2017 Nov 28, 2017	BUY	N/A	8,800	8,800 $208,000

672

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.9B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.